Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors

被引:33
|
作者
Hernandez, Silvia
Toll, Agusti
Baselga, Eulalia
Ribe, Adriana
Azua-Romeo, Javier
Pujol, Ramon M.
Real, Francisco X.
机构
[1] Inst Municipal Invest Med, Unitat Biol Celular & Mol, E-08003 Barcelona, Spain
[2] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[3] Univ Zaragoza, Dept Anat & Histol, Barcelona, Spain
[4] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[5] Hosp del Mar, Serv Dermatol, Barcelona, Spain
[6] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain
关键词
D O I
10.1038/sj.jid.5700705
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Epidermal nevi (EN) are benign lesions presenting at birth or in childhood. Based on the occurrence of fibroblast growth factor receptor 3 (,FGFR3) mutations in seborrheic keratosis and urothelial carcinomas (UC), and the identification of two young patients with EN and UC, we hypothesized that mutations might occur in EN. The R248C mutation was found in 6/23 (26.1%) EN but it was absent from unaffected skin. In two patients with EN and UC, both lesions were FGFR3 wild type. Our findings indicate that: (1) FGFR3 mutations occur in mosaicism and can cause EN and (2) other genes are involved in EN.
引用
收藏
页码:1664 / 1666
页数:3
相关论文
共 50 条
  • [21] Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer
    Gust, Kilian M.
    McConkey, David J.
    Awrey, Shannon
    Hegarty, Paul K.
    Qing, Jing
    Bondaruk, Jolanta
    Ashkenazi, Avi
    Czerniak, Bogdan
    Dinney, Colin P.
    Black, Peter C.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (07) : 1245 - 1254
  • [22] Localization of acidic fibroblast growth factor, fibroblast growth factor receptor-4, transforming growth factor-α, and epidermal growth factor receptor in human endocrine cells of the gut and related tumors:: An immunohistochemical study
    La Rosa, S
    Uccella, S
    Capella, C
    Chiaravalli, AM
    Sessa, F
    APPLIED IMMUNOHISTOCHEMISTRY, 1998, 6 (04): : 199 - 208
  • [23] Fibroblast growth factor receptor (FGFR)-3 as a suitable target in bladder cancer
    Gust, Kilian M.
    McConkey, David J.
    Hegarty, Paul K.
    Bondaruk, Jolanta E.
    Czerniak, Bogdan A.
    Dinney, Colin P.
    Black, Peter C.
    CANCER RESEARCH, 2011, 71
  • [24] Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism
    Horton W.A.
    Lunstrum G.P.
    Reviews in Endocrine and Metabolic Disorders, 2002, 3 (4) : 381 - 385
  • [25] Epidermal growth factor receptor mutations in lung cancers
    Yatabe, Yasushi
    Mitsudomi, Tetsuya
    PATHOLOGY INTERNATIONAL, 2007, 57 (05) : 233 - 244
  • [26] CHARACTERIZATION AND QUANTITATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN INVASIVE AND SUPERFICIAL BLADDER-TUMORS
    SMITH, K
    FENNELLY, JA
    NEAL, DE
    HALL, RR
    HARRIS, AL
    CANCER RESEARCH, 1989, 49 (21) : 5810 - 5815
  • [27] Epidermal growth factor receptor mutations in lung adenocarcinoma
    Siegelin, Markus D.
    Borczuk, Alain C.
    LABORATORY INVESTIGATION, 2014, 94 (02) : 129 - 137
  • [28] Mutations and Response to Epidermal Growth Factor Receptor Inhibitors
    Laurent-Puig, Pierre
    Lievre, Astrid
    Blons, Helene
    CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1133 - 1139
  • [29] Epidermal growth factor receptor mutations in lung cancer
    Sreenath V. Sharma
    Daphne W. Bell
    Jeffrey Settleman
    Daniel A. Haber
    Nature Reviews Cancer, 2007, 7 : 169 - 181
  • [30] Epidermal growth factor receptor mutations in lung cancer
    Sharma, Sreenath V.
    Bell, Daphne W.
    Settleman, Jeffrey
    Haber, Daniel A.
    NATURE REVIEWS CANCER, 2007, 7 (03) : 169 - 181